We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
194 hedge funds and large institutions have $2.24B invested in Denali Therapeutics in 2023 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 77 increasing their positions, 57 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
195% more call options, than puts
Call options by funds: $2.06M | Put options by funds: $697K
35% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 57
0.19% more ownership
Funds ownership: 78.86% → 79.06% (+0.19%)
4% less funds holding
Funds holding: 203 → 194 (-9)
19% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 36
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
29% less capital invested
Capital invested by funds: $3.18B → $2.24B (-$938M)
Holders
194
Holders Change
-9
Holders Change %
-4.43%
% of All Funds
3.08%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
29
Increased
77
Reduced
57
Closed
36
Calls
$2.06M
Puts
$697K
Net Calls
+$1.36M
Net Calls Change
+$542K
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$21.2M |
| 2 |
BlackRock
New York
|
+$19.8M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$18.8M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$7.82M |
Top Sellers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$13M |
| 3 |
Man Group
London,
United Kingdom
|
-$12.8M |
| 4 |
Millennium Management
New York
|
-$9.13M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$8.47M |
